Daniel K. Schwartz receives funding from the US Department of Energy, the National Science Foundation, and the National Institutes of Health. Ankur Gupta receives funding from the National Science ...
Glioblastomas are one of the most malignant and lethal cancers. Despite recent treatment advancements, median survival is only 12 to 16 months. In 2015, the Optune device, a novel, non-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results